Estrogen-related receptor gamma (ERR-γ) and ERβ increase positive estrogen-like influences in the prostate, and ERR-γ has been shown to slow proliferation in prostate and breast cancer cell lines [72–74]. Here, ESR2 is linked to breast carcinoma.